Mechanically, TPX2 mediates prostate cancer EMT through cyclin-dependent kinase (CDK1)-regulated phosphorylation of ERK/GSK3β/SNAIL pathway [73]. The gene discussed is GSK3B; the disease is prostate carcinoma.